Rubén Spretz
Affiliations: | 2001-2005 | The University of Nebraska - Lincoln, Lincoln, NE |
Google:
"Rubén Spretz"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Capolla S, Colombo F, De Maso L, et al. (2023) Surface antibody changes protein corona both in human and mouse serum but not final opsonization and elimination of targeted polymeric nanoparticles. Journal of Nanobiotechnology. 21: 376 |
| Voce DJ, Bernal GM, Wu L, et al. (2019) Temozolomide treatment induces lncRNA MALAT1 in an NF-кB and p53 co-dependent manner in glioblastoma. Cancer Research |
| Capolla S, Mezzaroba N, Zorzet S, et al. (2016) A new approach for the treatment of CLL using chlorambucil/hydroxychloroquine-loaded anti-CD20 nanoparticles Nano Research. 9: 537-548 |
| Capolla S, Garrovo C, Zorzet S, et al. (2015) Targeted tumor imaging of anti-CD20-polymeric nanoparticles developed for the diagnosis of B-cell malignancies. International Journal of Nanomedicine. 10: 4099-109 |
| Mansour NM, Bernal GM, Wu L, et al. (2015) Decoy Receptor DcR1 Is Induced in a p50/Bcl3-Dependent Manner and Attenuates the Efficacy of Temozolomide. Cancer Research. 75: 2039-48 |
| Capolla S, Bomben R, Zorzet S, et al. (2015) Targeted Nanoparticles for the Delivery of Antagomir17: New Approach for the Treatment of Chronic Lymphocytic Leukemia Blood. 126: 5293-5293 |
| Bernal GM, LaRiviere MJ, Mansour N, et al. (2014) Convection-enhanced delivery and in vivo imaging of polymeric nanoparticles for the treatment of malignant glioma. Nanomedicine : Nanotechnology, Biology, and Medicine. 10: 149-57 |
| Mezzaroba N, Zorzet S, Secco E, et al. (2013) New potential therapeutic approach for the treatment of B-Cell malignancies using chlorambucil/hydroxychloroquine-loaded anti-CD20 nanoparticles. Plos One. 8: e74216 |
| Mansilla E, Díaz Aquino V, Zambón D, et al. (2011) Could metabolic syndrome, lipodystrophy, and aging be mesenchymal stem cell exhaustion syndromes? Stem Cells International. 2011: 943216 |
| Mansilla E, Marín G, Roque G, et al. (2011) 5.58 Advances in the Use of Targeted Nanoparticles for the Treatment of B-CLL Clinical Lymphoma Myeloma and Leukemia. 11: S284 |